Introduction
============

The use of Matrix Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) for identification of microbial specimens has scaled up dramatically over the past decade due to the continual improvement of available tools, including expanded spectral peak databases \[reviewed in [@B12]; [@B31]; and [@B2]\]. Species identification of bacteria is now honed to strain-specific and subspecies distinctions in many cases ([@B28]; [@B17]) as well as the characterization of non-bacterial organisms such as fungi ([@B8]; [@B24]). These approaches are relatively rapid, inexpensive, and accurate for use in clinical diagnostics ([@B28]), environmental sample analysis, food safety, and other applications ([@B6]; [@B13]). MALDI-TOF MS is increasingly utilized to distinguish clinically relevant nontuberculous mycobacteria (NTM) ([@B24]; [@B9]).

The *Mycobacterium avium* complex (MAC) comprises several clinically important mycobacterial species including *M. avium* (subsp. *hominissuis*), *M. intracellulare*, and *M. chimaera* ([@B11]; [@B14]), among others \[e.g., *M. colombiense* ([@B27]) and *M. yongonense* ([@B7])\]. Although *M. avium* and *M. intracellulare* species are more frequently observed in clinical cases, a recent series of *M. chimaera* infections originating in cardiac surgery suites ([@B37]) illuminates the importance of identifying members of the MAC complex at the species level in a rapid and accurate manner. While the spectrum of *M. avium* is relatively distinct from the other two species, *M. intracellulare* and *M. chimaera* are highly similar to each other ([@B36]), and not readily distinguished using the standard approaches of most MALDI-TOF peak interpretation algorithms ([@B4]; [@B25]). Pulmonary infections caused by the different MAC species are distinct in their virulence and clinical features, indicating that species-level identification is important for effective prognostics ([@B5]; [@B20]). Bruker Daltonik (Bremen, Germany) developed a commercially available algorithm to differentiate *M. chimaera* and *M. intracellulare* from each other using only MALDI-TOF peak data. This algorithm was found to perform well against 59 bacterial isolates of European origin using the internal transcribed spacer (ITS) sequence to identify species ([@B30]). Here we set out to evaluate the same MALDI algorithm against 111 isolates of United States origin. Sequence from the *rpoB* locus was used to determine species, but in 16 discrepant cases, the isolates were whole genome sequenced and species identity was determined using phylogenomics.

Materials and Methods {#s1}
=====================

NTM Species Determination Using Sanger Sequencing
-------------------------------------------------

All samples were of clinical origin within the United States, either bronchoalveolar lavage, sputum, or tissue. Isolates were sent to National Jewish Health for NTM species identification and/or antimicrobial susceptibility testing. DNA from these isolated cultures of 300 acid-fast bacilli were analyzed using a targeted 711 base pair region of the *rpoB* locus that was Sanger sequenced using ABI 3730xL and queried against the National Center for Biotechnology Information (NCBI) Basic Local Alignment Search Tool (BLAST) database. The *rpoB* target is one of several recommended for NTM species determination according to current national clinical microbiology guidelines ([@B14]); other targets that are utilized for this purpose are 16S rRNA, secA, ITS, and hsp65 ([@B23]). From this collection, a subset (185) were identified as one of the MAC species according to rpoB sequence, i.e., *M. avium* (*n* = 74*), M. intracellulare* (*n* = 55), or *M. chimaera* (*n* = 56).

MALDI-TOF MS
------------

MAC strains were subcultured onto Middlebrook 7H11 agar media and incubated for 7--10 days to obtain sufficient biomass for MALDI-TOF MS identification. Colonies from the 7H11 plates were harvested and heat-killed in high performance liquid chromatography (HPLC) grade water, followed by acetonitrile/formic acid extraction procedure according to the manufacturer protocol. The MALDI-TOF target was spotted with 1 μL of extract supernatant and overlaid with 1 μL of α-Cyano-4-hydroxycinnamic acid (HCCA) matrix prior to data capture using the Bruker MALDI-TOF Biotyper system (software v4.0). A minimum score of 1.8 was required. A complete MALDI spectrum dataset was sent to Germany for MALDI spectrum analysis in parallel at Bruker Daltonik in Bremen, Germany.

For samples identified by MALDI-TOF MS as *M. chimaera-intracellulare* group, a second-tier analysis was performed using a recently developed research subtyping software from Bruker Daltonik \[([@B30]) herein referred to as MBT Subtyping Module\]. One sample, NTM-184, was eliminated from the sensitivity and specificity calculations because the MALDI results placed it in the *M. chimaera-intracellulare* group, but the *rpoB* result was *M. avium*, and this sample did not have whole genome sequence (WGS) information (see below.) An additional seven samples, six of which were identified as *M. chimaera* using *rpoB*, were also eliminated from these calculations because the MBT Subtyping Module did not yield a result. These strains are listed in Table [1](#T1){ref-type="table"} under the MBT Subtyper as "*M. chim/M. int.*" It should be noted that the MBT Subtyping Module returned a high score on these seven samples but because it was unable to distinguish the two species, it does not make a call in these cases.

###### 

Comparison of single locus sequencing results to whole genome sequencing results for sixteen MAC strains for each sample that was whole genome sequenced, three loci were extracted and analyzed by BLAST to the non-redundant NCBI database giving the results listed.

            Region extracted from WGS data                                                                   
  --------- -------------------------------- ----------- --------------------- ----------- ----------------- -----------
  NTM-006   *M. chim/M.int*                  *M. int*    *M. chim/M.int*       *M. chim*   *M. int*          *M. int*
  NTM-168   MAC                              *M. int*    *M. chim/M.int*       *M. int*    *M. chim/M.int*   *M. int*
  NTM-224   *M. mars/M.int*                  *M. chim*   *M. int*              *M. chim*   *M. chim/M.int*   *M. chim*
  NTM-105   MAC                              *M. int*    *M. chim/M.int*       *M. chim*   *M. int*          *M. chim*
  NTM-206   MAC                              *M. int*    *M. chim/M.int*       *M. chim*   *M. int*          *M. chim*
  NTM-035   MAC                              *M. int*    missing data          *M. chim*   *M. int*          *M. chim*
  NTM-232   MAC                              *M. int*    *M. chim/M.int*       *M. chim*   *M. int*          *M. chim*
  NTM-019   *M. chim/M.int*                  *M. int*    *M. chim/M.int*       *M. chim*   *M. int*          *M. chim*
  NTM-178   MAC                              *M. int*    *M. chim/M.int*       *M. chim*   *M. int*          *M. chim*
  NTM-107   MAC                              *M. int*    *M. chim/M.int*       *M. chim*   *M. int*          *M. chim*
  NTM-054   *M. mars/M.int*                  *M. chim*   *M. int/M.int yong*   *M. chim*   *M. int*          *M. chim*
  NTM-223   MAC                              *M. int*    *M. int*              *M. chim*   *M. chim/M.int*   *M. chim*
  NTM-203   MAC                              *M. int*    *M. int*              *M. chim*   *M. chim/M.int*   *M. chim*
  NTM-208   MAC                              *M. int*    *M. int*              *M. chim*   *M. chim/M.int*   *M. chim*
  NTM-204   MAC                              *M. int*    *M. int*              *M. chim*   *M. chim/M.int*   *M. chim*
  NTM-230   *M. chim*                        *M. chim*   *M. chim*             *M. chim*   *M. chim/M.int*   *M. chim*

Also listed are the species as determined using only the 403 SNP from 16S, assuming a strain was previously identified as belonging to the chimaera/intracellulare group. MBT Subtyper result and the WGS species call based on phylogenomic tree. M. chim = M. chimaera, M. int = M. intracellulare, M. yong = M. yongonense, M. mars = M. marseillense.

Phylogenomic Analysis of Ambiguous NTM Strains
----------------------------------------------

For almost all samples, the *rpoB* species identification was considered to be the actual species of that strain. In a few cases, samples yielded discrepant results, and for these samples, WGS was used to assign a species identification to a given mycobacterial strain. Genomic DNA was isolated according to a protocol adapted from [@B19], employing a column DNA clean in lieu of a phenol chloroform extraction and alcohol precipitation. Genomic libraries were constructed using Nextera XT and sequenced using Illumina chemistry (Illumina, Inc., San Diego, CA).

Illumina reads were trimmed of adapters and low quality bases (\< Q20) using Skewer ([@B18]). Trimmed reads were assembled into scaffolds using Unicycler ([@B38]), and genome assemblies were compared against a selection of reference genomes to calculate average nucleotide identities (ANI, chjp/ANI on [GitHub.com](http://github.com/), Supplementary Table [S1](#SM1){ref-type="supplementary-material"}) and to assign a species call to each isolate ([@B15]; [@B32]). Trimmed reads and background reference genomes were mapped to the *M. chimaera* CDC 2015-22-71 genome ([@B16]) using Bowtie2 software ([@B22]). Single nucleotide polymorphisms (SNPs) were called using SAMtools mpileup program ([@B26]), and a multi-fasta sequence alignment was created from concatenated basecalls from all strains ([@B10]; [@B29]). Resulting sequences were used to make a maximum likelihood (ML) phylogenetic tree using RAxML-NG with a GTR+G substitution model ([@B21]) and 1,000 bootstrap replicates. The tree was annotated and visualized with ggtree ([@B39]). Reference genomes for the tree are, for *M. chimaera*, listing genome name, accession number: AH16, [CP012885.2](CP012885.2); CDC 2015-22-71,CP019221.1; DSM 44623, [CP015278.1](CP015278.1); SJ42, [CP022223.1](CP022223.1); ZUERICH-2, CP015267.1; LJHL01, [LJHL00000000.1](LJHL00000000.1); LJHM01, LJHM00000000.1; LJHN01, LJHN00000000.1; 1956, CP009499.1; ATCC 13950, NC_016946.1; MOTT-02, NC_016947.1; MOTT-64, NC_016948.1; and for *M. intracellulare*: 1956, CP009499.1; ATCC 13950, NC_016946.1; MOTT-02, NC_016947.1; MOTT-64, [NC_016948.1](NC_016948.1).

The whole genome sequence data are available at NCBI in Bioproject number [PRJNA506060](PRJNA506060)^[1](#fn01){ref-type="fn"}^ with the following accession numbers: NTM-006, [SAMN10441865](SAMN10441865); NTM-019, SAMN10 441945; NTM-035, [SAMN10441946](SAMN10441946); NTM-054, SAMN1044 1947; NTM-105, SAMN10441948; NTM-107, SAMN10441949; NTM-168, SAMN10441950; NTM-178, SAMN10441951; NTM-203, SAMN10441952; NTM-204, SAMN10441953; NTM-206, SAMN10441954; NTM-208, SAMN10441955; NTM-223, SAMN 10441956; NTM-224, SAMN10441957; NTM-230, SAMN10 441958; NTM-232, [SAMN10441959](SAMN10441959).

Comparison of WGS to Single Locus Species Determination
-------------------------------------------------------

Using primer sequences of known targets, three regions were extracted from the WGS data. These were previously targeted regions from the following loci: 16S rDNA ([@B34]; [@B36]), the 16S--23S internal transcribed spacer (ITS) ([@B33]), and *rpoB* ([@B1]; [@B3]). These sequences were used to BLAST against the non-redundant NCBI database and the top species call or calls are reported in Table [1](#T1){ref-type="table"}.

Results
=======

From the initial strain collection, 185 isolates were identified by *rpoB* amplicon sequencing as one of the three prominent clinical MAC species, specifically 74 *M. avium*, 55 *M. intracellulare*, and 56 *M. chimaera.* These 185 strains were then analyzed using MALDI-TOF MS at National Jewish Health, in Denver, Colorado, United States and the data were re-analyzed in Bremen, Germany, yielding identical results according to the Biotyper 4.0 software. Of the 74 *M. avium* isolates, 73 were identified as *M. avium*. A single *M. avium* sample (as identified by *rpoB*) and the remaining 111 samples were all identified as being in the *M. chimaera-intracellulare* group.

These 112 strains were then subjected to a second tier of analysis wherein their MALDI-TOF MS spectra were evaluated using the recently developed MBT Subtyping Module software; see Methods ([@B30]). One sample, NTM-006, was identified as *M. chimaera* by *rpoB* but as *M. intracellulare* by WGS, thus the sample was categorized as *M. intracellulare*. This was the only sample for which WGS yielded a result that differed from *rpoB*. In this case, the WGS result was considered to be the actual species for calculations. After removing the eight samples that were unconfirmed (see Methods), the samples numbered 55 *M. intracellulare* and 49 *M. chimaera* that were suitable to evaluate the MBT Subtyping Module algorithm for its ability to distinguish these two species.

Sixteen isolates were selected for WGS. These strains were investigated in greater depth using extracted sequences of specific loci (Table [1](#T1){ref-type="table"}) in addition to phylogenomic tree analysis using the WGS data (Figure [1](#F1){ref-type="fig"}). The specific loci were selected to reflect the regions that are most commonly used for mycobacterial species identification. For most Mycobacteria spp., these loci are useful for identifying to the NTM species level. But the close relationship of *M. chimaera* and *M. intracellulare* is apparent in these genes since the two species' sequences over these regions are largely interchangeable, consistent with the initial confounding observations that led to the naming of *M. chimaera* ([@B35]). Based on these extracted sequences, the *rpoB* fragment was most reflective of the WGS result (Table [1](#T1){ref-type="table"}).

![*Mycobacterium chimaera and Mycobacterium intracellulare* whole genome phylogenomic tree. Available whole genome data from *M. chimaera* and *M. intracellulare* were used to visualize the relationships of 16 strains for this study (in blue) and 13 reference strains in comparison to the reference genome of *M. chimaera* CDC 2015-22-71. Bootstrap support values are given at nodes, scale bar for SNP distances is at bottom of figure.](fmicb-09-03140-g001){#F1}

For the 49 samples identified by sequencing as *M. chimaera*, the MBT Subtyping Module identified 40 as *M. chimaera* and 9 as *M. intracellulare* for a sensitivity of 81.6%. However, because all of the Subtyper *M. chimaera* calls were in fact *M. chimaera* according to whole genome sequencing, the positive predictive value for a call of *M. chimaera* is 100%. The *M. intracellulare* (*n* = 55) data differed in that all 55 samples were identified as *M. intracellulare* for a sensitivity of 100%, but nine of the *M. chimaera* samples were called *M. intracellulare* by the Subtyping software, reducing the specificity, and the positive predictive value is 86% or 55/(55+9). This indicates that a minority (∼18%, or 9/49) of the true *M. chimaera* samples would be recognized as *M. intracellulare* using the MALDI Biotyper Compass software.

Discussion
==========

The recent outbreak of *M. chimaera*-contaminated heater-cooler devices used in cardiac surgery has increased the clinical urgency for differentiating *M. chimaera* from *M. intracellulare*. The MALDI-TOF MS approach to species identification is less expensive and more rapid than sequencing methods, but until now has been unable to distinguish these two closely related MAC species. Our findings indicate that a call of *M. chimaera* by the Bruker subtyping algorithm tested here is correct every time for a positive predictive value of 100%. We also found that a call of *M. intracellulare* is correct 86% of the time, that is, 14% of our samples that were recognized as *M. intracellulare* by MALDI are actually more closely related to *M. chimaera* than to *M. intracellulare*. Given the regional diversity of NTM species, it is possible that these strains were not available in the initial European sample set during test design. A number of these strains cluster more closely with the *M. chimaera* reference strains (samples 178, 019, 232, etc.), although they are arguably relatively distant from any available reference. The dynamic nature of bacterial phylogenomics requires us to integrate currently available references and whole genome approaches with an understanding that species nomenclature is always evolving as new branches and clades become apparent.

With increasing numbers of *M. chimaera* and *M. intracellulare* isolates requiring species identification in diagnostic reference laboratories, it is clear that improved tools are needed to quickly and accurately identify and distinguish these close mycobacterial species, in most cases inseparable using average nucleotide identity measures (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). We observe a qualitative difference in genome size for these two species and performed a statistical comparison of available complete reference genomes from *M. chimaera* (mean ± 1s.d., 6.24 ± 0.29Mb, *n* = 8) and *M. intracellulare* (5.52 ± 0.12Mb, *n* = 6), and found that *M. chimaera* was consistently larger by ∼700,000 bases (*p* \< 0.001, Mann-Whitney U test.) This information may provide a path to discovering markers that can distinguish the two species, but the standard and reliable tools used to distinguish most NTM from one another often fail to discriminate between these very closely related strains. The discerning capability of the Bruker Subtyper module with MALDI spectral data offers an available and notable advance in MAC species identification.
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